8630
Sompo Holdings, Inc.
“egaku” Strategy in Nursing Care and Seniors Business
- Group CEO, Chairman and Representative Executive Officer Kengo Sakurada
7013
IHI Corporation
Financial Results for Third Quarter FY2022(IFRS) (for the year ending March 31, 2023)
- Executive Officer General Manager of Finance & Accounting Division Yasuaki Fukumoto
8604
Nomura Holdings, Inc.
Third Quarter Operating Results for Fiscal Year Ending March 2023
- CFO Takumi Kitamura
8766
Tokio Marine Holdings, Inc.
Tokio Marine Insights 「Global Leader in Specialty Insurance」
- Susan Rivera HCC Insurance Holdings, Inc. Chief Executive Officer
9229
SUNWELS Co.,Ltd.
FY March 2023, Second Quarter Financial Highlights
- President and Representative Director Ryotatsu Nawashiro
8766
Tokio Marine Holdings, Inc.
Tokio Marine Group Business Strategy
- President and Group CEO Satoru Komiya
8252
Marui Group., Ltd.
Overview of Performance in Six Months Ended September 30, 2022
- Managing Executive Officer, CFO Hirotsugu Kato
7013
IHI Corporation
Financial Results for Second Quarter FY2022 (IFRS) (for the year ending March 31,2023)
- President and CEO Hiroshi Ide
4523
Eisai Co., Ltd.
Q2 FY2022 (Fiscal Year Ending March 31, 2023) Financial Results Presentation
- Representative Corporate Officer and CEO Haruo Naito
4523
Eisai Co., Ltd.
Eisai Media/Investor Conference
- Representative Corporate Officer and CEO Haruo Naito
4523
Eisai Co., Ltd.
Q1 FY2022 (Fiscal Year Ending March 31, 2023) Financial Results Presentation
- Tatsuyuki Yasuno Senior Vice President Chief Financial Officer Chief IR Officer
4503
Astellas Pharma Inc.
Astellas Earnings Call -Q1/FY2022 Financial Results -
- Chief Financial Officer (CFO) Minoru Kikuoka
8766
Tokio Marine Holdings, Inc.
Tokio Marine Insights 「Power to overcome a challenge」
- Tokio Marine Kiln Group Chief Executive Officer Brad Irick
8766
Tokio Marine Holdings, Inc.
Tokio Marine Group Business Strategy
- President and Group CEO Satoru Komiya
8252
Marui Group., Ltd.
Financial Results Briefing for the Fiscal Year Ended March 31, 2022
- President and Representative Director, Representative Executive Officer, CEO Hiroshi Aoi
4523
Eisai Co., Ltd.
FY2021 (Fiscal Year Ended March 31, 2022) Financial Results Presentation
- Representative Corporate Officer and CEO Haruo Naito
4503
Astellas Pharma Inc.
FY2021 financial Results ended March 31, 2022
- President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
8766
Tokio Marine Holdings, Inc.
D&I at Tokio Marine Group
- Mika Nabeshima, Group Chief Diversity & Inclusion Officer (CDIO), Tokio Marine Holdings
4503
Astellas Pharma Inc.
R&D Meeting -Initiatives for Gene Therapy-
- President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
8630
Sompo Holdings, Inc.
Overview of Overseas Insurance Business
- CEO of Overseas Insurance and Reinsurance Business James Shea
4503
Astellas Pharma Inc.
Sustainability Meeting
- Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
4503
Astellas Pharma Inc.
Astellas Earnings Call -Financial Results for the Q3 of FY2021-
- Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
4503
Astellas Pharma Inc.
R&D meeting -New research organization structure -
- Representative Director, Executive Vice President, Chief Strategy Officer (CStO) and Chief Financial Officer (CFO), Chief Business Officer (CBO) Naoki Okamura
8766
Tokio Marine Holdings, Inc.
Tokio Marine Group Business Strategy
- President and Group CEO Satoru Komiya
8252
Marui Group., Ltd.
Overview of Performance in Six Months Ended September 30,2021
- President and Representative Director, Representative Executive Officer, CEO Hiroshi Aoi
4503
Astellas Pharma Inc.
Astellas Earnings Call -Financial Results for the Q2 of FY2021-
- Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
8630
Sompo Holdings, Inc.
New Mid-Term Management Plan (Domestic Life / Nursing Care & Seniors Business)
- Yasuhiro Oba CEO of Domestic Life Insurance Business
8252
Marui Group., Ltd.
MARUI IR DAY
- Managing Executive Officer, President and Representative Director, Epos Card Co., Ltd. Yoshionori Saito
4503
Astellas Pharma Inc.
CSP2021（CSP: Corporate Strategic Plan）
- Representative Director, President and Chief Executive Officer (CEO) Kenji Yasukawa, Ph.D.
4503
Astellas Pharma Inc.
Rx+ Day
- Executive Vice President, Chief Strategy Officer and Chief Financial Officer
Naoki Okamura
4536
Santen Pharmaceutical Co., Ltd.
Q2 FY2020 Results
- President & Chief Executive Officer Shigeo Taniuchi
8252
Marui Group., Ltd.
Financial Results Briefing for the Fiscal Year Ended March 31, 2020 and Future Outlook
- President and Representative Director, MARUI GROUP CO., LTD. Hiroshi Aoi
4536
Santen Pharmaceutical Co., Ltd.
Financial Disclosure Meeting FY2019 Business Highlights FY2020 Forecast
- President & Chief Executive Officer Shigeo Taniuchi
8252
Marui Group., Ltd.
MARUI IR DAY 2019. 12
- Hiroshi Aoi President and Representative Director, MARUI GROUP CO., LTD.
Precautions in use
Nomura IR assumes no responsibility for correctness, validity or any other nature of the contents on this server.
No act such as alteration, modification or addition to the contents is permitted.
Since the contents on this server are not intended to solicit investment, our company has no liability for any trouble related to investment made by any audience based on the contents of this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity or any other nature of information, including its format and details, obtained from any site linked from our site.